Navigation Links
Epstein-Barr Virus (EBV) VCA IFA IgG

ProductsEpstein-Barr Virus (EBV) VCA IFA IgG
Company Focus Diagnostics
Item Epstein-Barr Virus (EBV) VCA IFA IgG
Features 
  • Complete System: Kits include all necessary reagents: 12-well slides, FITC/or DTAF labeled conjugate, and negative and positive titered controls.
  • Enhanced Readability: Substrate slides show a crisp, bright apple green fluorescent pattern for positive specimens which are distinct against a background of red counter-stained negative cells.
  • Integrated EBNA Control: The EBNA substrate slide combines positive and negative cells at a standard ratio, eliminating the need for a separate control slide in each assay.
  • Enhanced EA Interpretation: The EBV Early Antigen Kit includes a specially formulated diluent to remove background non-specific staining.
  • Recombinant VCA IgM: The recombinant substrate eliminates the problem of interference from early antigen expression which occurs in substrate slides prepared with a human lymphocyte line.
Description Indirect immunofluorescent antibody (IFA) test for the detection and semi-quantitation of human serum IgG antibodies to Epstein-Barr viral capsid antigen (VCA). Each kit contains ten 12-well slides, FITC IgG conjugate, and positive and negative controls.
Info Focus Diagnostics
Customer Service: 714-503-2003
Web site: http://www.focusdx.com

Related medicine products :

1. Epstein-Barr Virus (EBV) Early Antigen IFA
2. Epstein-Barr Nuclear Antigen (EBNA) ACIF (Anti-Complement Immunofluorescence)
3. Epstein-Barr Virus (EBV) VCA IgM Recombinant IFA (RIFA)
4. Epstein-Barr virus (EBV) ELISA
5. Epstein-Barr Virus EBNA-1 IgG II
6. Epstein-Barr Virus EBV-VCA IgG II
7. Epstein-Barr Virus EBV-EA IgG II
8. Epstein-Barr Virus EBV-VCA IgM II
9. Epstein-Barr Virus (EBV) Probe, Paraffin
10. Epstein-Barr Virus Antibody Panel II
11. Epstein-Barr Virus Antibody Panel I
H2003 manage your patient records and billing processes via the Web.
The OmniMD Medical Billing system allows a practice to manage patient billing and accounting. It is integrated with the EMR, appointment system and charge capture. The system interfaces with electron
athenaCollector™ is athenahealth's revenue cycle and practice management solution. It provides medical office automation and billing capabilities in the industry. With athenaCollector, your clai
...ty Urea (Nitrogen) powder reagent once reconstitut...ngle liquid stability to help maximize laboratory ...quick result turnaround time. The patented technol... provides a long shelf life and stability once rec...
Medicine Products:
(Date:12/3/2008)... ECPI College of Technology has extended its mi...rans who have served in Iraq or Afghanistan. This ...ll 2005 and is also available to spouses and depen...e regions. Up to $150,000 in scholarships is avail...e of Technology or Medical Careers Institute, the ...
(Date:12/3/2008)...ssive surgeries were free of tumor recurrence an a...HESTER, Minn., Dec. 3 A...w-grade gliomas survived longest when they underwe... entire tumor. If safely removing the entire tumor... longer when surgery was followed by radiation the...
(Date:12/3/2008)...Half Times Greater Than Entire U.S. Economy , ...the federal government stopped the Medicare and So...ore payroll taxes and allowing no more accrual of ...to those who have already earned these benefits, a... Policy Analysis (NCPA). , , "The numbers...
(Date:12/3/2008)..., Dec. 3 ThermoGenesis,...ovative products and services,that process and st... a,conference call on Thursday, December 4, to di...nsition at the Company. , The conference ca...,(8:30 a.m., Eastern Standard Time). The call can ...
Breaking Medicine News(10 mins):Health News: ECPI College of Technology and Medical Careers Institute Announce Extension for South Carolina Military Scholarship Opportunity 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 3Health News:Medicare, Social Security Owe Up to $52 Trillion to Current Retirees and Workers 2Health News:ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition 2
...pharmaceutical firm is close to developing the wor...re and neighbouring countries battle outbreaks, a... 3,000 people will begin by early next year in Tha...enne, GlaxoSmithKline Biologicals president. "We'...
...niversity researchers say that a single drug for k...ents with type 2 diabetes under check may soon be ..., Professor of Medicine and Pharmacology at Tulane...s that the compound colesevelam HCl, in combinatio...
... dengue fever in Thailand have risen 36 percent si...epidemic of the mosquito-borne disease swept the r...land and affected more than 21,000 since the begin...nglish-language Nation newspaper reported, quoting...
...ch woman who received the world's first face trans...ut admitted she still looks at herself in the mir...am back in the world of humans, those who have a f...ch allow them to communicate. And I am alive again...
Other Medicine News:Health News:World's First Face Transplant Patient Feels She is Alive Again 2
(Date:12/1/2008)...GO, Dec. 2 New research...ht-slice computed tomography (CT) scanner in an em... of stroke victims who receive a potentially life-...at North Shore Medical Center (NSMC)-Salem Hospita...annual meeting of the Radiological Society of Nort...
(Date:12/1/2008)...PORE, Dec. 1 S*BIO Pte Ltd today a...ial of SB1518, a potent and orally-active JAK2 inh...r patients with chronic idiopathic myelofibrosis (...te the safety and tolerability of SB1518 in patien...ients. The Phase 1 part of the study will assess ...
(Date:12/1/2008)... Abstinence is still the best policy , , R... A new study from Mayo Clinic finds the use of the...lcoholic hepatitis, an acute inflammation of the l...he results of the study are published in the Decem...ojournal.org/ ). , , VIDEO ALERT: Addition...
(Date:12/1/2008)...TA, Dec. 1 GeoVax Labs, ... biotechnology company developing,human vaccines ...cy Virus) and,other infectious agents, announced ...ne Trials will take place in twelve sites across N...d in collaboration with The National Institutes of...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3AARP to Host Discussion and Debate Watch Event 16897 1AARP to Host Discussion and Debate Watch Event 16897 2AARP to Host Discussion and Debate Watch Event 16897 3BioHorizons Announces the Purchase of Implant Logic Systems 4624 1BioHorizons Announces the Purchase of Implant Logic Systems 4624 2American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance 4620 1American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance 4620 2American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance 4620 3American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance 4620 4Drug Proves Effective in Slowing Melanomas 16892 1Drug Proves Effective in Slowing Melanomas 16892 2
...e/ -- (SEND2PRESS,NEWSWIRE) -- Epeius Biotechnolog... a historic landmark in medical oncology and a,def...gene therapy.,The first clinical report of its kin...ue of the International Journal of,Oncology, Vol.3...res of tumor destruction observed in chemo-resista...
...e-FirstCall/ --,Nuvelo, Inc. today announced the p...el monoclonal antibodies against the,cell-surface ...a,potential new target for immunotherapy of B-cell...e study, entitled "The lymphoid,cell surface recep...leukemia and lymphoma therapeutics," appears in th...
Other Medicine Technology:News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 2Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 3Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 4